Log in

ABS Arctic Bioscience AS OSL · Norway

Arctic Bioscience AS (ABS) news

Arctic Bioscience AS is a public biotech or pharmaceutical company listed on OSL under the ticker ABS, recorded under Norway. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Arctic Bioscience AS news

We have not published a story on Arctic Bioscience AS yet. When there is news, it will appear here.

Questions about Arctic Bioscience AS

What is the ticker symbol of Arctic Bioscience AS?

Arctic Bioscience AS trades under the ticker ABS on OSL.

Where is Arctic Bioscience AS listed?

Arctic Bioscience AS is listed on OSL.

Which country or territory is Arctic Bioscience AS listed under?

Our directory records Arctic Bioscience AS under Norway.

What does Arctic Bioscience AS do?

Our directory classifies Arctic Bioscience AS as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Arctic Bioscience AS?

The ISIN recorded for Arctic Bioscience AS is NO0010859580.

Does aibio.space cover Arctic Bioscience AS?

aibio.space lists Arctic Bioscience AS among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Arctic Bioscience AS?

Companies in our directory listed in the same country and business area as Arctic Bioscience AS: Nykode Therapeutics ASA, Lytix Biopharma ASA, Vistin Pharma ASA, Oncoinvent ASA, Circio Holding ASA, Zelluna ASA.

Investor discussion: Arctic Bioscience AS

Members talk about Arctic Bioscience AS (ABS). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OSL:ABS on TradingView.

Listing details

Arctic Bioscience AS is a public biotech or pharmaceutical company listed on OSL under the ticker ABS, recorded under Norway. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Arctic Bioscience AS
Ticker
ABS
Listing
OSL
Country or territory
Norway
Business scope
Pharmaceuticals: Major
ISIN
NO0010859580
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.